| Financial Year |
March 31 2023 |
| Monetary Funds |
461,796,675.32 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
76,950.00 |
| Accounts Receivable |
1,169,080,606.54 |
| Advances to Suppliers |
74,389,780.17 |
| Other Receivables |
21,968,515.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,611,721,135.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
42,920,446.32 |
| Total Current Assets |
3,585,760,974.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
30,573,865.08 |
| Long-term Equity Investment |
6,228,816.40 |
| Investment Properties |
24,345,357.58 |
| Fixed Assetes |
229,521,882.46 |
| Under-construction Projects |
69,420,413.19 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
47,498,224.08 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,260,362.87 |
| Deferred Income Tax Assets |
56,105,650.49 |
| Other Non-Current Assets |
12,900,267.50 |
| Sub-Total of Non-Current Assets |
534,510,377.32 |
| Total Assets |
4,120,271,351.99 |
| Short-Term Loans |
410,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
233,176,832.15 |
| Accounts Payable |
822,219,386.84 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
20,628,517.30 |
| Taxes Payable |
25,430,120.28 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
16,808,204.91 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,302,159.38 |
| Other Current Liabilities |
84,141,528.39 |
| Sub-Total of Current Liabilities |
2,555,935,179.61 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
45,678.08 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
38,153,544.33 |
| Total Liabilities |
2,594,088,723.94 |
| Paid-In Capital(Or Share Stock) |
116,168,002.00 |
| Capital Surplus |
797,044,382.47 |
| Surplus Reserve |
39,922,396.14 |
| LESS:Treasury Stock |
9,846,788.40 |
| Undistributed Profits |
513,060,379.83 |
| Minority Stockholder's Interest |
42,663,469.51 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,483,519,158.54 |
| Owner's Equity（Stockholder's Equity） |
1,526,182,628.05 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,120,271,351.99 |
